BIOGEN INC. REGISTERED SHARES DL-,0005
Technische Signale
| Signale Details | |
|---|---|
| WKN / ISIN | - / US09062X1037 |
| Börse | Hannover |
| Schluss | 160,25 |
| Spekulatives Signal |  25.10.24 |
| MACD | 11.10.24 |
| Momentum |  07.05.24 |
| Bollinger Bands | 17.07.24 |
| TBI | 06.05.24 |
| Schnitt GD 90 | 18.10.24 |
Analystenbewertung
| Bewertungstrend | aktuell | Vorwoche | Vormonat |
|---|---|---|---|
| Bewertung | 1,88 | 1,86 | 1,79 |
| Anzahl der Analysten | 32 | 35 | 34 |
| Kaufen | 14 | 15 | 16 |
| Übergewichten | 8 | 10 | 9 |
| Halten | 10 | 10 | 9 |
| Untergewichten | 0 | 0 | 0 |
| Verkaufen | 0 | 0 | 0 |
| Aktueller Durchschnitt von insgesamt 32 Analysten: 1,88 | |||
| Planzahlen (in EUR) | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Umsatz | 9,84 Mrd. | 9,52 Mrd. | 9,56 Mrd. |
| EBIT | 0 | 2,88 Mrd. | 3,09 Mrd. |
| EBITDA | 0 | 3,35 Mrd. | 3,47 Mrd. |
| Nettoverschuldung** | 3,94 Mrd. | 3,21 Mrd. | 741,53 Mio. |
Umsatz |
EBIT |
EBITDA |
Nettoverschuldung** |
| Dividende | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Dividende / Aktie | 0,00 EUR | 0,00 USD | 0,00 USD |
| Dividendenrendite | 0,00% | 0,00% | 0,00% |
Dividende / Aktie (in USD) |
Dividendenrendite (in %) |
||
| Analystenhäuser |
|---|
| Argus Research Company,Atlantic Equities LLP,Baird,Baptista Research,Barclays,BMO Capital Markets Equity Research,BMO Capital Markets U.S. (Historical),BofA Global Research,Brean Capital,BTIG,BWS Financial Inc.,Canaccord Genuity,Cantor Fitzgerald & Co.,CFRA Equity Research,Citadel Securities, LLC,Citigroup Inc,Credit Suisse,Crisp Idea,Daiwa Capital Markets America Inc.,Daiwa Securities Co. Ltd.,Deutsche Bank,Dz Bank Ag,Equisights,Erste Group Bank AG,Eugene Investment & Securities Co Ltd.,Evercore ISI,FBR Capital Markets & Co.,First Global Stockbroking (P) Ltd.,Goldman Sachs,Guggenheim Securities, LLC,H.C. Wainwright & Co.,HSBC,ISI Group Inc.,J.P. Morgan,Jefferies LLC,JMP Securities,Lazard Capital Markets,Leerink Partners LLC,Mizuho Securities USA LLC,Morgan Stanley,Morningstar Inc.,Needham & Company,Nomura Securities Co. Ltd.,Oppenheimer & Co. Inc.,Piper Sandler Companies,Raymond James & Associates,RBC Capital Markets,Redburn Atlantic,Sanford C. Bernstein & Co., LLC,Scotiabank Global Banking and Market,Soleil Securities Group, Inc.,Stifel, Equities Research,TD Cowen,Truist Securities,UBS Investment Bank,Wedbush Securities Inc.,Wells Fargo Securities, LLC,William Blair & Company L.L.C.,Wolfe Research, LLC.,Zephirin Group, Inc. |
| Hinweis |
|---|
|
Selected Data supplied by Standard & Poors
* Unabhängige Schätzung (Gewinnwachstum (in %)) ** Nettobargeldbestand bei negativen Schätzungen |